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Leukocyte infiltration, ICAM-1 and VCAM-1 distribution in 15 cases of
primary renal vasculitis. MP. Rastaldi, F. Ferrario, S. Tunesi, P. Napo-
dano, A. Beltrame, and G. D'Amico, Department of Nephroloi, S. Carlo
Hospital, Milan, Italy. We have studied, by the immunohistochemical
method, the leukocyte infiltration and the expression of adhesion mole-
cules ICAM-1 and VCAM-1, both glomerular and interstitial, in the renal
biopsies (RB) of 15 patients with the clinical and morphological diagnosis
of primary renal vasculitis (7 WG, 5 MPA, 3 "idiopathic necrotizing GN").
All 15 cases presented an important interstitial diffuse infiltrate of
macrophages (mv. 931/mm2) and T lymphocytes (mv. 809/mm2) with a
CD4/CD8 ratio of 3.0. About of these cells were ICAM-1 or VCAM-1
positive. Ten cases with periglomerular granulomatous reactions showed a
great infiltration with macrophages concentrated in the middle of the
lesion. The glomerular expression of VCAM-1 had a strict correlation with
the site and the extension of necrotizing/extracapillary lesions and with the
intensity of intraglomerular macrophage infiltration. The intensity of
ICAM-1 positivity also correlated with the glomerular damage with an
aspecific and more diffuse pattern. Our data show a marked infiltration of
macrophages and T lymphocytes in primary renal vasculitis, bearing out
the pathogenetic role of the cellular-mediated immunity in this disease.
Moreover, the presence of adhesion molecules in glomerular and inter-
stitial lesions confirms their importance in regulating the leukocyte
infiltration and in the interactions among the inflammatory cells.
Removal of constitutive and inducible nitric oxide synthase-blocking
compounds during hemodialysis. CE. Ruva, F. Bussolino, M. Arese, A.
Bosia, C. Navino, and G. Verzetti, Division of Nephrology and Dialysis,
Novara, and Department of Genetica Biologia e Chimica Medico, Torino,
Italy. The alteration of nitric oxide (NO) synthesis can be of importance in
the pathogenesis of uremic syndrome. In this study we evaluated the effect
of uremic plasma regulation on enzymes producing NO synthases (NOS).
We used three cellular types having different levels of NOS activity:
human endothelial cells from umbilical cord vein (HUVEC) containing
constitutive NOS (eNOS) with low enzymatic activity, a tEnd.1 murine
endothelial cell line with a high NOS activity expressing eNOS as well as
an inducible isoform, and a J774 murine macrophage line characterized by
a cytokine inducible NOS (iNOS). We examined three different subject
groups: group I, 45 patients with end-stage renal failure on regular
hemodialysis therapy; group II, 15 uremic patients on conservative therapy
with creatinine clearance lower than 50 mI/mm; group III, 20 healthy
subjects. We demonstrated that the majority (83%) of end-stage uremic
plasma samples inhibited NOS activity in tEnd.1 and in cytokine induced
J774, whereas they were ineffective on HUVEC. Seventeen percent of
plasma samples increased NOS activity in tEnd.1 and in J774 cells. The
inhibitory effect of plasma from dialyzed patients was not dependent on
the type of hemodialysis treatment. Plasma samples from patients with
moderate renal failure also inhibited NOS activity in tEnd.1, suggesting
that the renal failure itself, rather than the hemodialytic therapy, was
responsible for the accumulation of molecules affecting NOS. The hemo-
dialysis treatment modified the effects of plasma on NOS activity. Plasma
samples taken after hemodialysis session showed a reduced inhibitory
activity, and in some cases it enhanced NOS activity. At the same time,
molecules reducing NOS activity accumulated in the ultrafiltrate. There-
fore, the effects of uremic plasma on NOS activity are due to a balance
between inhibitor and activator factors.
Autoregulation of PTH secretion. C. Zoccali, F. Mallamaci, D. Leonar-
dis, M Postorino, S. Parlongo, and L. Messineo, Division of Nephrology and
CNR, Reggio Cal, Italy. Calcium and Calcitriol are the main factors that
regulate PTH secretion. It has been shown that self-regulation by "ultra-
short control loops" plays a role in the regulation of some hormonal
systems. The possibility that PTH secretion is self-regulated, however, has
received little attention. We tested the influence of a non-calcemic dose of
PTH138 (Bissendorf, Hannover) on plasma PTH184 in 7 subjects with
normal renal function. After baseline blood sampling we injected a bolus
dose of PTH135 (0.06 pg/kg) followed by a continuous infusion (0.06
tg/kg/hr) of the same compound. Blood sampling was repeated 45
minutes after starting the PTH138 infusion and 30 minutes after having
induced a slight increase in Ca by an i.v. infusion of calcium gluconate.
In the control experiment (placebo: 2 ml of saline in bolus, followed by a
5 mI/hr saline infusion) we repeated the same experimental sequence with
an identical timing of blood sampling PTH138 infusion which did not
change plasma Ca (baseline: 1.22 0.05mmol/liter, after 45 minutes of
PTH138 infusion: 1.22 0.05 mmol/liter). Plasma intact PTH184 concen-
tration fell consistently by 20% from 40 12 pg/mI to 32 10 pg/mI (P
< 0.01). Calcium gluconate infusion caused a comparable increase in
Ca in the two experiments (placebo: +0.031 0.031 mmol/liter;
PTH138: +0.038 0.018 mmol/liter). Parathyroid suppression, however,
was significantly more pronounced (P < 0.01) during PTH138 infusion
(from 32 10 pg/mI to 16 6 pg/mI) than during the placebo infusion
(from 36 12 to 28 7 pg/ml). PTH38 infusion suppresses endogenous
PTH1.84 and potentiates the effect of calcium on PTH secretion. The
results support the hypothesis that PTH secretion is self-regulated.
Cell specific regulation by TGFj3 of renal ECM expression. G.M.
Ghiggeri, R. Oleggini, F. Valenti, P. Altieri, F. Ginevri, F. Perfumo, R.
Ravazzolo, and R. Gusmano, Department of Nephrology, G. Gaslini Institute
of Genoa (I), Genoa and I.Bi. G. University of Genova (I), Italy. TGFf3 is a
potential determinant of tubulointerstitial fibrosis; however, a clear dem-
onstration of a fibrogenic effect of TGF!3 with renal cells is still lacking.
We evaluated whether TGFI3 (0—5 ng/ml) modulates the expression of
collagens by tubular epithelial cells (NRK52E) and interstitial fibroblasts
(NRK49F and Cvi). Collagens were extracted from 3H proline labeled
cells after partial pepsin digestion and were analyzed by SDS-PAGE and
autoradiography. Observed was a cell specific effect of TGFII which
up-modulated the expression of [a (111)3] by NRK52E (+200%), while
inhibiting interstitial fibroblasts. Parallel experiments performed on ho-
mologous cells transfected with the promoter of al (III) collagen gene
linked to luciferase demonstrated a comparable effect of TGFI3 on al (III)
collagen transcription in NRK52E. These observations indicate a stimu-
latory effect of TGF on both transcription and expression of al (III)
collagen by tubular epithelial cells. This mechanism is potentially impli-
cated in ECM regulation during tubulointerstitial fibrosis.
Erythrocyte Ca transport in idiopathic hypercalciuria: Relation to Ca
intestinal absorption and bone mineral density. G. Vezzoli, MC. Reina, L.
Soldati, G.L. Moro, A. Rubinacc4 P. Rigatti, and G. Bianchi, Division of
Nephrology and Dialysis, S. Raffaele Hospital, Milan, Italy. The relationship
between cell membrane Ca transport and Ca metabolism was evaluated in
idiopathic hypercalciuria (IH). We studied Ca-ATPase activity and passive
Ca influx in erythrocytes obtained from 56 patients with nephrolithiasis: 29
of them had IH (calcium excretion> 100 tmol/kg bodywt), and the other
363
364 Abstracts
37 patients were normocalciuric. Ca-ATPase was measured in washed
erythrocyte membranes at Vm using a coupled enzyme assay. Ca influx
was evaluated measuring strontium influx in washed erythrocytes, incu-
bated with Sr (3 mM) in the presence of vanadate (Ca-ATPase inhibitor).
Moreover, intestinal absorption of Ca was studied using an oral load of
stable Sr (2.65 mg/kg body wt) and expressed as the fractional absorption
of the administered oral dose after 1 hour; bone mineral density of lumbar
vertebrae (BMD L1-L4) and femur (BMD F) was assessed by dual x-ray
absorptiometry. Ca absorption (20% 1.3 vs. 14% 1; P < 0.005) and
Ca-ATPase activity (50 2.4 vs. 41 2.7 nmol ATP split/mm/mg; P <
0.02) were increased in patients with IH. Sr influx was not different in the
2 groups (55 4.9 vs. 52 5.0 smol/liter erythrocytes after 40 mm).
Ca-ATPase activity was positively correlated with calciuria (r = 0.24; P <
0.05), but not with the values of Ca intestinal absorption. When hypercal-
ciuric patients were considered, Ca-ATPase was positively correlated with
BMD L1-L4 (r = 0.42; P < 0.05) and BMD F (r = 0.46; P < 0.05). Sr influx
was not correlated with Ca metabolism parameters. Patients with IH were
divided in 2 subgroups according to their mean value of Ca-ATPase
activity: the first with activity < 50 (N = 16) and the other > 50. The value
of BMD F was significantly lower in the first subgroup (857 23 g/cm2 vs.
965 36; P < 0.025), whereas BMD L1-L4 was slightly lower (931 34
vs. 1018 34). The other parameters were not different. These results
suggest that membrane Ca-ATPase activity is increased in IH, especially in
the patients with normal bone mineral density. Bone and tubular cells
have a Ca-ATPase similar to that found in erythrocytes. It is possible that
the increase of Ca-ATPase activity prevents BMD reduction by limiting
urine Ca wastage or influencing bone cell function.
A new genic mutation in a family affected by X-linked nephrogenic
diabetes insipidus (ND!) and intracranial calcifications (IC). R. Bellan-
tuono, M. Giordano, S. Simonetti, F. Papadia, F. Carnevale, D. G. Bichet,
and D.A. Caringella, Nephrology and Dialysis Division, Metabolic Diseases
and Medical Genetic Division, Pediatric Hospital "Giovanni XXIII," Ban,
Italy, and University of Montréal, Montréal, Quebec, Canada. Hereditary
NDI is a rare disease in which the renal collecting tubule cells fail to
respond to antidiuretic hormone (arginine vasopressin) due to the pres-
ence of a mutation in the gene for the V2 receptor. This gene is located in
chromosome region Xq28. We recently studied a family from a Southern
Italian region, Puglia, in which two male cousins (10 and 9 years of age)
were affected by NDI. Computed tomography revealed bilateral and
multicentric IC. A detailed study of the family pedigree showed a third
affected member with neurological damage. He was a mother's uncle of
the probandi. Moreover, four other brothers of the last member men-
tioned died in their first year of age due to unknown causes. Segregation
analysis of the three affected members by polymerase chain reaction
(PCR) showed the presence of a mutation in the reading frame of the V2
receptor gene. The disease is segregating with the 2900 base pair (bp)
alleles also present in the mothers of the probandi (obligate carriers), in
their mother (grandmother of the probandi), and in a proband's sister.
This study allowed the identification of a new mutation associated with
NDI. There are 16 more mutations described in the literature associated
with the disease. Up to now, 7 cases of NDI and IC were described. None
of them was studied by molecular analysis. It is to be determined whether
IC are a phenotypical consequence of the same mutation, or the effect of
hypernatremia during the first months of life.
IgA nephropathy: Expression of smooth muscle a-actin in mesangial
cells. C. Oliva, G. Pecci, GA. Cinotti, and P. Barsotti, Departments of
Experimental Medicine and Nephrology, "La Sapienza" University, Rome,
Italy. Expression of smooth muscle a-actin (aSMA) has been demon-
strated in proliferating mesangial cells and has been proposed as a marker
of mesangial cell activation. Mesangial cells expressing the aSMA pheno-
type might contribute to modulating glomerular lesions and renal injury
progression in IgA nephropathy (IgAN). To verify this hypothesis, we
evaluated oSMA expression, using an anti-oSMA mab (Dako), in 30 renal
biopsies from 30 patients with IgAN (25 M, 5 F; aged: 10—54 years).
a-SMA data (evaluated by means of a semiquantitative arbitrary scale)
were compared with the level of glomerular proliferation (evaluated as
number of anti-PCNA mab positive nuclei/glomerular section), graded
histological lesions and clinical aspects. In our patients with IgAN,
up-regulation of mesangial sSMA expression (with a mean score of 2.1
0.2 SEM) was observed. aSMA score was higher (P < 0.01) in the biopsies
with grade V lesions. It showed a positive correlation with the grade of
extracapillary lesions (P < 0.05), with the presence of endocapillary
exudation (P < 0.05), and with the glomerular proliferation index (mean
value of 1.6 0.4 SEM, P > 0.05). Thus, it is possible to suggest that in
IgAN, mesangial synthesis of aSMA may be an early step in the
glomerular response to mediators of inflammation. It is also worth noting
that in patients who experienced a recent (1 year) episode of macro-
scopic hematuria at time of the biopsy the aSMA score showed a negative
correlation (NS) with the time lapse between the macro-hematuria and
the renal biopsy. The possible role of the mesangial aSMA phenotype in
effecting the renal damage progression in IgAN remains an attractive
hypothesis. Of interest is the observation of a lower aSMA expression
(1.87 0.2 to 2.53 0.4, NS) in biopsies from patients with macroscopic
hematuria (a subgroup of patients who has been reported to have a better
prognosis) and of a higher level of aSMA (3.18 0.3 to 1.87 0.2, P <
0.01) in the 2 patients with normal GFR at the biopsy time and renal
function impairment at the follow-up.
Increased Ca absorption in Bartter syndrome with hypocalciuria
(Gitelman syndrome). A. Bettinelli, G. Vezzoli, MG. Metta, P. Casirati,
MC. Reina, and E. Basilico, Division of Nephrology, Dialysis and Hyperten-
sion, S. Raffaele Hospital, and Second Division of Pediatrics, University of
Milan, Milan, Italy. Hypocalciuria is the peculiar feature of Gitelman
syndrome which differentiates it from Bartter syndrome. Both diseases
present alkalosis, hypokalemia, and hypomagnesemia. The cause of
decreased Ca excretion in Gitelman syndrome is unknown. It is also
unknown if Ca transport is altered in both intestine and kidney. Therefore,
we have studied Ca enteral absorption in 10 patients with Gitelman
syndrome, in their healthy brothers (N = 8), in their parents (N = 13), and
in 10 healthy controls. Ca enteral absorption was evaluated according to
the method of Reid et al using an oral load of stable strontium (2.65 mg/kg
body wt) and expressed as the fractional absorption (FA Sr) of the
administered oral dose after 1 and 4 hours. Patients had magnesemia <
0.7 mat, kalemia < 3.5 mat, and bicarbonatemia > 28; their 24 hour Ca
excretion was < 0.08 mM/mM creatinine. Sr absorption was significantly
increased in patients 4 hours after Sr oral administration (P < 0.05 vs.
other groups; ANOVA and Fisher test), whereas it was only slightly
increased after 1 hour. Moreover, 24 hour Ca excretion was significantly
decreased with reduced Ca fractional excretion (P < 0.05), whereas Cl and
K fractional excretions were significantly increased in patients (P < 0.05).
Age
FASr1
hr
%
FASr4
hr
%
Uca/Cr
(M/M)
Patients 16 3 21 5.4 30 9.7 0.030 0.02
Brothers 15 4 19 6.3 20 5.9 0.19 0.14
Parents 44 6 15 4.1 22 6.8 0.31 0.21
Controls 21 8 16 5.7 25 5.7 0.38 0.21
FA Sr at 4 hours was negatively correlated with magnesemia values (r =
—0.7; P < 0.05) and 24 hour Mg excretion (r = —0.72; P < 0.05) in
patients with Gitelman Syndrome. It was not significantly correlated with
calcemia (r =
—0.57; P = 0.08). Our results suggest that both enteral
absorption and tubular reabsorption of Ca are increased in Gitelman
Syndrome. The same Ca transport defect may be present in enterocytes
and kidney tubular cells and cause the alterations found in our patients.
HLA-DRB1 genes and susceptibility to Henoch-Schönlein (HS). A.
Amoroso, M. Berrino, L. Canale, M Comaglia, S. Guarrera, and G. Mazzola
on behalf of the Collaborative Study of "Gnippo Italiano di Immunopato-
log/a Renale" on HS syndrome, Department of Genetics, University of
Torino, Torino, Italy. Environmental factors, such as infections, are
implicated in the pathogenesis of HS in susceptible individuals. To
investigate the genetic components of the disease susceptibility, restriction
fragment length polymorphism (RFLP) analysis of HLA-DR beta, DO
alpha and beta genes and RFLP analysis of switch regions of the
immunoglobulin (Ig) heavy chain constant genes were carried out. HLA
class II typing was performed for 152 HS patients, 105 of whom with renal
involvement, and 42 patients were also studied for IgA switch RFLPs. The
gene frequencies of the alleles at these loci were compared between
patients and Italian controls. The frequencies of DRB1*01 and DRB1*11
were significantly increased in patients in respect to controls (P < 0.009
Abstracts 365
and P < 0.05, respectively), while DRB1*1501 and DRB1*07 were
reduced (P < 0.05 and P < 0.002, respectively). PCR-SSO typing of
DR1+ and DR11+ individuals revealed that DRB1* 1104 was significantly
more represented in patients than in controls (57% of DR11+ patients
and 27% of DR11+ controls) while DRB1*1101 was less frequent in
DR11+ patients (30%) than in DR11+ controls (61%; P = 0.0001).
DQB1 and DQA1 alleles showed frequencies in patients and controls in
accordance with the well-known linkage disequilibria (LD) with DRB1
alleles: DQA1*0101 and DQB1*0501 alleles (in LD with DRB1*0101)
were increased in patients while DQA1*02 and DQB1*0201 (in LD with
DRB1*07) were reduced. No differences were found comparing HS
patients with or without findings of kidney disease. Subdividing patients
with renal disease according to the presence of DRB1*01 or DRB1*11
alleles, the mean age at biopsy was earlier in positive patients (22.6 18
years) than in negative patients (30.9 21; P = 0.002), and the mean
number of relapse episodes per patient was higher in the first group (3.6
2 vs. 1.7 9; P = 0.04). Frequencies of RFLPs at IgA switch regions
were similar in patients and controls. These results support the hypothesis
that genetic factors may contribute to HS susceptibility. In particular, the
presence of arginine at position 71 of DRB1 chain (shared by DR1 and
DR1 1 alleles) seems to confer a higher risk of disease, while the presence
of isoleucine at position 67 of DRB1 chain (coded by both DR15 and DR7
genes) seems to confer protection. We may hypothesize that these
aminoacidic residues of DRB1 molecules are relevant in presentation to T
cells of some peptides against which the immune system reacts, leading to
HS manifestations.
ANCA isotype in ANCA positive vasculitis with pulmonary hemorrhage.
G. Gregorini, A. Sinico, P. Tira, G.P. Bosi, S. Tunes4 G. Palmerio, and R.
Majorca, Department of Nephrology and Pulmonary Function Laboratory
Spedali Civili and University of Brescia, Department of Nephrology, S. Carlo
Hospital, Milan, Italy. 1gM ANCA have been found in conjunction with
IgG ANCA in the subgroup of patients who develop pulmonary hemor-
rhage (PH) due to diffuse alveolar capillaritis. Due to the intravascular
distribution and longer persistence in the blood of this class of antibodies,
1gM ANCA have been suggested to sustain a pathogenic role in PH.
Consequently, 1gM ANCA tests were recommended in all ANCA positive
patients and treatment with plasma exchange systems that efficiently
remove 1gM was suggested in positive patients. We retrospectively looked
for 1gM ANCA in the first serum of 70 patients with IgG ANCA positive
vasculitis, 24 patients with C-ANCA and 46 with P-ANCA. 1gM ANCA
were detected by both indirect IF and by ELISA using as antigens purified
MPO and alpha granules, and 24/70 patients had pulmonary hemorrhage.
PH was diagnosed on the basis of presence of hemoptysis, radiological
interstitial-alveolar opacification, and raised coefficient of diffusing capac-
ity of CO (more than 30% of predicted normal). 1gM ANCA turned out
positive in 26/70 patients. 1gM ANCA specificity was the same as IgG
ANCA. 1gM ANCA were found in 15/24 (58%) patients with PH and in
11/46 (24%) patients without PH confirming a prevalence of 1gM ANCA
in the group of patients with PH (P < 0.001). Patients with 1gM ANCA
and no PH did not develop PH after a long follow-up. PH in 15 patients
with 1gM ANCA was not more severe than in 9 patients who were 1gM
ANCA negative; however, PH relapsed in only two patients who were 1gM
ANCA positive. Presence of 1gM ANCA did not correlate with the
presence of rheumatoid factor. Serum levels of total 1gM were significantly
higher in 1gM ANCA positive patients than in 1gM ANCA negative
patients (148 36 mg/dl vs. 106 68 mg/dIP < 0.002). Our data confirm
the association between 1gM ANCA and PH. However, severe PH can
develop in patients who were 1gM ANCA negative and patients could
have for long time high titers of 1gM ANCA without any evidence of PH.
Total levels of 1gM seem to be related to the presence of 1gM ANCA.
Nitric oxide (NO) production during dialysis: In vitro evaluation by a
new test. A. Amore, R. Bonaudo, D. Ghigo, F. Bussolino, B. Gianoglio, P.
Cirina, C. Costamagna, L. Peruzzi, and R. Coppo, Department of Nephrology
and Dialysis, Regina Margherita Children's Hospital, and Genetic and
Biochemistry Department, University of Torino, Torino, Italy. The evaluation
of dialysis biocompatibility, as circulating molecules and lympho-mono-
cyte products, does not examine directely the endothelial (E) reactivity,
triggered by mediator release. NO is a powerful vasoactive product of E
origin and its major effect is a vasodilation leading to hypotension. We
present an original assay to test the effects of the interaction between
blood-dialysis membrane and the F layer. To this aim the NO production
by E cells in culture (EC) was measured after the mediator release
induced by dialysis (HE). Three in vitro HE sessions were performed using
cuprophane (Cu) and polymethylmethacrylate (PMMA) membranes. Re-
circulating donor blood samples at 0, 5, 15, 30 and 60 minutes were
coincubated with murine EC for 6 hours. Then, mRNA for inducible NO
synthase (NOS) and NOS activity as H3-citrulline produced from H3-
arginine were measured. IL-i and TNF released after 6 hours of lympho-
monocytes cultures were also detected. The time course of the NO
synthase activity of EC is reported: at the 15th minute values were greater
with Cu than PMMA (P < 0.01). EC mRNA for inducible NOS was
expressed more after Cu than PMMA HD. IL-i and TNF produced after
a 6 hour incubation paralleled the NO profile. In conclusion, the Cu
membrane enhanced the production of NO, and the endothelial mediator
provided an immediate vasodilatory effect and long-term vasosclerotic
potential.
Time, minutes
Symbols are: (0) Cu; (•) PMMA. P=O.01.
Integrin expression on mesangial cells: Modulatory role of IgA, abnor-
mally glycosylated IgA, and IgA/IgG and IgAllectin aggregates. L. Peruzzi,
A. Amore, P. Cirina, B. Gianoglio, MG. Porcellini, L. Trusolino, P.C.
Marchisio, and R. Coppo, Department of Nephrology and Dialysis Regina
Maigherita Children's Hospita4 and Biomedical Science and Human Oncol-
ogy Department, Histology Section, University of Torino, Torino, Italy.
Cultured mesangial cells (MC) express cell-matrix adhesion receptors,
including the widest and best known family of integrins. They constitute
focal contacts between MC and glomerular basement membrane (GBM),
fundamental for the regulation of glomerular hemodynamics. We inves-
tigated whether integrin expression on cultured human MC could be
modulated by native IgA or pre-treated by carbohydrate specific enzymes
or IgA/IgG and IgA/lectin aggregates. Human MC displayed strong
adhesion to glass coverslips in basal conditions and expressed mostly
alpha3-33 and at lower intensity 31 chains of integrins, as judged by
immunofluorescence staining. After 12 hours MC produced large amount
of fibronectin (F) and laminin (L). Polymeric IgA and even more
aggregated IgA and aggregated IgAJIgG strongly decreased MC adhesion,
integrin expression, and MC matrix production. On the contrary, Con A
and IgA aggregated with Con A increased /31, /33 and alpha3 expression.
IgA pretreated with mannosidase and neuraminidase allowed increased
adhesion of MC in comparison to untreated IgA, while adhesion was
decreased on IgA treated with NAc-galactosidase, fucosidase, NAc-
glucosaminidase. The expression of /33 chain as well as the production of
fibronectin and laminin were variously influenced by the IgA glycosylation.
Our data suggest that the interactions of native polymeric IgA, IgA with
altered glycosylation, aggregated IgA or IgA/IgG or IgA/lectins result in
structural rearrangement of glomerular integrins. This phenomenon might
lead to modifications in the transmission of MC contraction to the GBM,
possibly regulating the glomerular hemodynamics and the production of
mesangial matrix.
Altered glycosylation of serum IgA in patients with IgA nephropathy. R.
Coppo, P. Cirina, P. Brusa, A. Amore, L. Peruzzi, B. Gianoglio, and L.
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Cattel, Department of Nephrology and Dialysis, Regina Margherita Hospital,
Chimica Farmaceutica Applicata Institute, University of Torino, Torino,
Italy. Several observations, including an abnormal binding of serum IgA to
some lectins and to mesangial matrix glycoproteins, are Consistent with the
hypothesis of an altered glycosylation of the IgA molecules in patients with
IgA nephropathy (IgAN). To investigate this pathogenetic mechanism, we
compared in healthy controls and IgAN patients the profile of IgA eluted
from Sepharose columns (4B-CNBr) conjugated with lectins. One lectin
from each of the 5 groups classified on the basis of their preferential
binding to sugar residues was used (a) concanavalin A, (b) wheat germ
agglutinin, (c) soybean, (d) ulex, (e) limulus. Affinity chromatography
bound proteins were eluted by the sugars corresponding to the lectins in
solid phase: (a) mannose, (b) N-Acetyl-glucosamine, (c) N-acetyl-galac-
tosamine, (d) L-fucose, (e) sialic acid. These were then examined by high
pressure liquid chromatography (HPLC; columns: Zorbax GF-250 and
Bio-sil SEC-250). Eluted peaks were analyzed by SDS-polyacrylamide gel
electrophoresis. By HPLC, sera from IgAN patients showed, in compari-
son to controls, a highly increased second peak of Con A binding IgA
eluted with mannose (300 kD) and a new peak at lower molecular weight
(150 kD). The sugar eluted peak was slightly higher in IgAN than in
controls in soybean and wheat germ agglutinin and ulex columns. Con-
versely, the binding capacity of the lectin limulus, specific for sialic acid,
was highly decreased in IgAN patients in comparison to controls. These
data suggest an altered glycosylation of IgA molecules in sera from
patients with IgAN, including a defective expression of sialic acid and an
increase in mannose contents.
Hyperfiltration and salt intake in mild to moderate essential hyperten-
sion. C. Zoccali, F. Mallamaci, and D. Leonardis, Divisione di Nefrologia e
CNR Centro di Fisiologia C/mica, Reggio Cal, Italy. There is now convincing
evidence that the GFR is raised in patients with mild to moderate essential
hypertension. Because high salt intake causes hyperfiltration and acceler-
ates the progression of renal damage in Dahl rats (a model of salt-sensitive
hypertension), we studied the influence of salt intake on the GFR in 14
patients with mild to moderate essential hypertension. Each patient was
studied in random order and according to a crossover design, at habitual
salt intake, at high salt intake (that is, habitual +50/100 mmol) and at low
salt intake (habitual —50/100 mmol). Protein, calcium and potassium
intake was fixed across the three study periods. High salt intake caused a
significant (P < 0.01) increase in MAP (low salt: 98 1; high salt: 109
2 mm Hg) and the expected suppression in PRA and in plasma aldoste-
rone. Seven patients manifested a MAP increase >10% and were arbi-
trarily classified as salt-sensitive. The GFR was significantly higher (P <
0.01) at high salt intake (137 12 mI/mm) than at habitual (124 9
mI/mm) and at low salt intake (106 7 mI/mm). In the aggregate urinary
salt excretion was directly related with the GFR (r = 0.56, P < 0.001) and
the slope of this relationship indicated that a 50 mmol/day increase in salt
intake is associated with a 13 mI/mm rise in the GFR. Although GFR
changes tended to be more marked in salt-sensitive (+31 mI/mm, range
0—81) than in salt-resistant hypertensives (+ 12 mI/mm, range —7—62) the
difference was not significant (P > 0.30) and there was no relationship
between changes in GFR and changes in MAP (r = 0.07). The GFR
response to salt loading was largely independent (r = 0.1—0.3, NS) of the
renin-aldosterone system. At fixed protein intake, changes in salt intake in
the physiological range are associated with important GFR changes in
mild to moderate essential hypertensives. Because a high GFR in these
patients may be a predictor of progressive renal damage, independently of
the effect on arterial pressure, high salt intake could be a factor that
contributes to nephron obsolescence in patients with essential hyperten-
sion.
Diabetes and renal replacement therapy (RRT) in Italy: Analysis of risk
factors. C. Catalano, C. Marino, M. Postorino, and P. lacopino. ANED (Ass
Naz Emodializzati), Centro di Fisiologia Clinica del CNR e Centro Trapianti
Midollo Osseo, Reggio Calabria, Italy. We identified factors which nega-
tively influenced the survival of Italian diabetic patients treated by RRT,
by following up those patients who were alive while on treatment on
December 31, 1987 (prevalent data), in relationship with a number of
putative risk factors. Information concerning diabetes was collected in
1988 while information concerning RRT and mortality data has been
gathered annually by the ANED. The first RRT mode of treatment was
defined as that which started during the first RRT month which lasted for
at least a month. At the end of 1987, 1,573 diabetic patients were treated
by dialysis or transplantation: 1286/1573 have been allocated to extracor-
poreal dialysis (ED), 281 to peritoneal dialysis (PD), while 6 have been
directly transplanted. Patients allocated to ED and PD were similar
according to age at diagnosis of diabetes (42 vs. 40 years), age at start of
RRT (57 vs. 56 years), M/F ratio (1.30 vs. 1.30), proportion of patients
with severe sight reduction (39% vs. 37%), and macrovascular complica-
tions. Overall survival projected at 60 months was 58%. Risk factor
analysis (Cox's proportional hazards regression function) showed that age(RR 1.5, P < 0.001), PD (RR 1.6, P < 0.001) and diabetes duration (RR
1.15, P < 0.01) were associated with a worse survival, while survival was
not influenced by sex, region of treatment and type of diabetes. The main
result of our study, confirmed both by the univariate and multivariate
analysis, is that Italian diabetic patients treated by PD have a lower
survival rate compared with those treated by ED. These results should be
confirmed by a prospective study.
Red cell Na,Li countertransport and evolution of IgA nephropathy. R.
Boero, A. Fabbri, E. Degli Esposti, A. Lucatello, A. Sturani, G. Fomeri.s, C.
Guarena, M Piazza, M. Fusaroli, and G. Piccoli, Istituto di Nefro-Urologia
dell'Università, Ospedale G. Bosco, Torino, and Ospedale S. Maria delle
Croci, Ravenna, Italy. It has been suggested that hyperactivity of red cell
Na,Li countertransport (CNT) may identify, among patients with IgA
nephropathy (IgAN), a subset characterized by higher prevalence of
arterial hypertension and lipid abnormalities, potentially with a less
favorable course of the disease. To test the prognostic significance of CNT
we followed prospectively the evolution of renal function in 48 patients
with IgAN (35 males, mean age 37 years, range 16—65), with a serum
creatinine <1.5 mg/dl at the determination of CNT (mean 1.06 0.03
mg/dl). Follow-up lasted 40 months on average (range 14—69). Data were
analyzed dividing patients into two groups with basal CNT lower or higher
than median value.
Na,Li countertransport
<Median >Median P
Cases 24 24 —
Males/females 16/8 19/5 NS
Age years 37 3 37 2 NS
Follow-up months 40 3 39 3 NS
Crs at baseline mg/dl 1.0 0.03 1.1 0.04 NS
Crs at follow-up mg/dl 1.0 0.04 1.9 0.45 0.003
zCrs mg/dl 0.003 0.023 0.75 0.43 0.007
SAP at follow-up mm Hg 132 3 130 3 NS
DAP at follow-up mm Hg 81 2 86 2 NS
Patients with ACE inhibitors 5 11 NS
It is unlikely that ACE inhibitors may have negatively influenced renal
function, since no acute deterioration was observed after start of therapy
and most patients were already on treatment at the beginning of follow-up.
In conclusion, patients with IgAN and higher values of CNT have a less
favorable renal prognosis.
Role of nitric oxide (NO) in renal autoregulation: Observations by
intravital microscopy. A. Cavarape, J. Hoffend, M Steinhausen, and E.
Bartoli, Department of Internal Medicine, University of Udine, Udine, Italy,
and First Institute of Physiology, University of Heidelberg, Heidelberg,
Gennany. Endothelial cells synthesize nitric oxide (NO), which is involved
in the maintenance of basal vascular tone in the renal and systemic
microcirculation. Controversy exists as to whether NO is also involved in
autoregulation of renal blood flow. The split hydronephrotic kidney of the
rat was developed as an experimental model for directly observing renal
microcirculation in videomicroscopy. In our study we directly measured
the in vivo changes of diameters in pre- and postglomerular vessels and
glomerular blood flow (GBF) after reduction of renal perfusion pressure
(RPP) and blockade of NO synthase. Furthermore, juxtamedullary (JM)
arterioles were directly compared in our study with cortical (C) vessels,
supplied by the same arcuate arteries. In control animals (N = 4) RPP
could be decreased by clamping the aorta above the renal arteries using a
micrometer screw from the basal value (mean 112 1.4 mm Hg) to 100,
90, 80 mm Hg. Diameters and GBF were measured 10 minutes after each
pressure step. A stepwise pressure-dependent vasodilation was observed
in arcuate, C interlobular arteries and C proximal afferent arteriole. C
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GBF decreased significantly only at a RPP of 80 mm Hg (—13.3 2.1%),
while GBF in JM vessels fell significantly even with a RPP of 100 mm Hg
(—13.9 3.6%), decreasing progressively as RRP was lowered to 90 mm
Hg (—30.1 2.7%) and 80mm Hg (—38.3 3.25%,P < 0.05). Diameters
of JM afferent and efferent arterioles tended to decrease with RPP
reduction. In the second experimental group (N = 8) NO synthase was
blocked by local administration in the tissue bath where the preparation
was immersed in 1 x iO at NG-nitro-L-arginine methyl ester (L-
NAME). Thirty minutes after L-NAME application, RPP was reduced
stepwise from baseline (mean 110 0.9mm Hg) to 100, 90 and 80mm Hg.
Arcuate arteries, C interlobular arteries and C afferent arterioles dilated
to a similar degree as in untreated animals. C GBF did not change
significantly even when RPP was lowered to 80 mm Hg. Afferent and
efferent arterioles of JM glomeruli dilated significantly at reduced RPP (P
< 0.05), and in contrast to untreated animals GBF did not fall over the
whole pressure range considered in this study. GBF JM was maintained
even with a RPP of 80 mm Hg (—13.1 11.9%). In conclusion,
pressure-dependent dilation of pre-glomerular vessels and autoregulation
of GBF was preserved in C vessels after L-NAME. In JM arterioles, which
do not autoregulate in our model, the pressure/flow relationship was
improved when NO synthesis was inhibited. Our data suggest that NO
release influences vascular responses and pressure/flow relationship in JM
vessels, but not autoregulation of C glomeruli.
HCV-RNA in serum, lymphocytes and cryoprecipitates of patients with
anti-HCV antibodies and type II cryoglobulinemia with renal involve-
ment. S. Savoldi, F. Scolari, R. Chiappini, M.G. Mann, A. Gussago, S.
Bresciani, M Puoti, G. Gregorini, and R. Majorca, Departments of Nephrol-
ogy, Chemistry and Infectious Disease, Universiiy of Brescia, Brescia, Italy.
The prevalence of HCV infection was evaluated in 22 patients with type II
cryoglobulinemia and renal involvement. Ten patients underwent renal
biopsy, showing membranoproliferative ON (8) and mesangioproliferative
GN (2). Clinically, liver disease was present in 15 patients. In 11 patients,
liver biopsy showed chronic active hepatitis (10 cases) and chronic
persistent hepatitis (1 case). No patient was HbsAg positive. Positivity for
markers of HBV infection was documented in 15 patients. The presence
of anti-HCV antibodies (Ab) was detected by ELISA II (Ortho) and
confirmed by RIBA II (Chiron); viral RNA was detected in serum,
ciyoprecipitate and lymphocytes by amplification technique RT-PCR
"nested" (5' UTR); the specificity of the PCR product was confirmed by
a non-isotopic hybridization system (DEJA, Sorin Biomedica). ELISA test
showed positivity in 21/23 serum samples (95.6%); RIBA confirmed
positivity in 19/19 (3 undetermined; 16 positive). HCV-RNA was detected
in the serum of 13/18 (72.2%) patients reacting to RIBA. HCV-RNA was
identified in the lymphocytes of 13/14 (92.8%) patients with anti-HCV Ab
in the serum. Cryoprecipitate of 10/11 (90.9%) patients showed the
presence of HCV-RNA. Anti-HCV Abs were detected in the clyoprecip-
itate (treated or not by D'lT) of 11/16 patients (68.7%). Of 5 patients
HCV-RNA negative in the serum, 1 was anti-HCV Ab negative in the
serum, 4 resulted HCV-RNA positive in the lymphocytes, and 3/4 were
positive in the cryoprecipitate. Conclusion: The finding of HCV-RNA in
the cryoprecipitate and in the lymphocytes of patients suggests that
infection persists even when HCV-RNA is not further detected in the
serum. The high prevalence of anti-HCV and of viral RNA in the serum
and in cryoprecipitate of our patients suggests a causative role of HCV
infection on the pathogenesis of type II cryoglobulinemia.
Repertoire of immune response to different HCV antigens and HLA
typing in patients with essential mixed cryoglobulinemia (EMC). S.
Savoldi, F. Scolari, R. Chiappin4 A. Gabrielli, M Clementi, M Puoti, M.
Salibeig, A. Amoroso, L. Canale, G. Gregorini, and R. Majorca, Chair of
Nephrology and of Infectious Disease, University of Brescia, Brescia, Depart-
ment of Internal Medicine, University of Ancona, Ancona; Department of
Genetics, University of Tonino, Tothio, Italy; Department of Clinical Virology,
Karolinska Institute, Stockholm, Sweden. To evaluate if abnormalities of
immune response to HCV infection play a role in the pathogenesis of
EMC, we studied 19 patients (15 F, 4 M) with EMC and renal involve-
ment. Anti-HCV antibodies (abs) were detected (ELISA H test) in 18/19
patients. In 18 patients with anti-HCV abs, we measured the levels of
serum IgG subclasses (IgG 1, IgG 3, IgG 4) directed to different epitopes
of the genomic viral proteins: 3 core peptides (1—28, 21—38, 51—68); 3 of
NS5 and 1 of NS4 (non-structural region); 1 of the envelope (structural
region). Moreover, typing of HLA genes of class II, DR beta, DO alpha
and DO beta (RFLP) was carried out. Abs reacting to one or more viral
peptides were found in all patients: 2 patients had abs directed to 1
peptide; 7 patients to 2 peptides; 6 patients to 3 peptides; 2 patients to 4
peptides. Serum samples of all patients were reacting to core peptides: 17
patients (94.4%) had abs against peptide 1—28 (14 IgG 1, 10 IgG 3, 8 IgG
4); 10 patients against 21—38 (10 IgG 1); 9 patients against 51—68 (8 IgG
1, 1 IgG 4). With regard to NSS, 3 patients had abs against peptide 1; 3
patients against peptide 2 (IgG 3); 1 patient (also reacting against peptide
1) had abs against peptide 3. No patients showed abs directed against NS4
and Envelope I antigens. HLA gene frequencies did not differ from those
of control population (108 healthy blood donors). Many DR 1 patients
recognized the peptide 1 of NS5 (P = 0.019). Our study confirms that
HCV infection, in association to female sex, is a predisposing factor to
EMC. More studies are needed to ascertain if the different repertoire of
immune response to different HCV antigens may play a role on patho-
genesis of EMC.
Familial IgA nephropathy (IgAN): Experience in an Italian center. F.
Scolani, S. Savold4 A. Amoroso, N Bossini, M Bracchi, and R. Majorca,
Chair of Nephrology, University of Brescia, Brescia, and Department of
Genetics, University of Torino, Torino, Italy. Biopsy-proven diagnosis of
IgAN was made in 140 patients at our institution from 1971 to 1992.
Genealogical investigation enabled us to discover different degrees of
familial relationships in 20 out of 140 (14%) patients, belonging to 8 family
groups. Typing of HLA genes of class II (RFLP) and C4A, C4B, Bf
phenotype analysis was carried out in some families. 1st family: (2 parents,
3 sons, 1 daughter): 2 brothers, sharing one HLA haplotype (bearing DR
beta 8, DO beta 3a, DQ alpha ib, C4A 3, C4B 1, Bf S) had IgAN. The
disease was identified in 2 additional members of the kindred, sharing the
same HLA haplotype, with a first-cousin relationship with the father. 2nd
family: (2 parents, 2 sons, 1 daughter): 1 son had IgAN; the brother who
did not share any HLA haplotype had clinical glomerulonephritis. IgAN
was diagnosed in a paternal aunt sharing one HLA haplotype (DR beta 4,
DO beta 3a, DO alpha 3, C4A 4, C4B 2, Bf S) and in a young male with
a first-cousin relationship. 3rd family: (2 parents, 2 sons, 1 daughter): the
father, 1 son and the daughter had IgAN. The affected children did not
share any HLA haplotype. 4th family: (2 parents, 2 sons, 1 daughter): 1
son and the daughter, sharing one HLA haplotype bearing DrR beta 1,
DO beta la, DO alpha la, C4A 3, C4B 1, Bf S, had IgAN. 5th family: (4
brothers, 3 sisters): 2 brothers, sharing HLA-DR beta 11, had IgAN. 6th
family: (2 parents, 1 son, 2 daughters): 1 son and 1 daughter had IgAN.
The other daughter had clinical glomerulonephritis. All patients shared
DR beta 1. 7th family: (mother, 3 sons): 2 brothers had IgAN. Immuno-
genetic study was not done. 8th family: (2 parents, 4 sons): the father and
one son, sharing HLA-Dr beta 13, had IgAN. Our data confirm a possible
genetic influence on pathogenesis of IgAN. More additional familial cases
are needed to ascertain the possible relation of IgAN to the HLA system.
Prediction of end-dialysis sodium plasma water concentration in PFD
through ultrafiltrate conductivity kinetic model. S. Di Filippo, M Corti, S.
Andrulli, and F Locatelli, Nephrology and Dialysis Department, Lecco
Hospital, Lecco, Italy. Clinical implementation of the sodium kinetic model
(NaKM) requires measurement of initial sodium plasma water concentra-
tion (Na) at the start of each dialysis session; consequently, NaKM is
seldom routinely applied. In PFD, ultrafiltrate conductivity (UFC) can be
continuously measured and, through an appropriate kinetic model, dialy-
sate and reinfusate conductivities necessary to obtain a target UFC can be
recognized. If UFC and Na are related linearly, the conductivity kinetic
model (CKM) may allow indirect routine implementation of NaKM.
Fourteen non-diabetic patients were selected for study. The validity of
CKM was evaluated by calculating the difference between end-dialysis
measured and predicted UFC (UFC M-P). Regression of measured Na
(NapwM) on UFC with 95% individual confidence limits was used to test
the power of prediction of the individual NaM from UFCM. Mean
value, standard deviation, and individual error of UFC M-P were —0.01,
0.05 and 0.10 mS/cm, respectively. The mean UFC M-P of —0.01 is very
small, not significantly different from 0 (t = 0.75, P = NS); thus, the
prediction value is unbiased. Individual error from predicted value was
less than 0.10 mS/cm supporting the validity of the UFC model. Regres-
sion of NaM on UFC is shown in the figure: between values of 14 and
15 mS/cm, the 95% confidence limits for the predicted individual value of
NaM show that individual error in predicting Na is less than 2
mEq/liter. In conclusion, CKM allows prediction of end-dialysis Na
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without the need for blood sampling and determinations; the clinical
effects of routine indirect NaKM implementation need to be evaluated.
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N=14; x coefficient = 9.6; constant = 6.49; r2 = 0.92.
Tolerance induction to kidney allograft induced by cotchicine in the rat.
0. Imberti, N. Perico, D. Ostermann, C. Barbui, M. Bontempelli, and G.
Remuzzi, Mario Negri Institute and Ospedali Riuniti, Be,gamo, Italy. Col-
chicine has been used with beneficial effects in autoimmune diseases. Here
we investigated the possibility that coichicine, by virtue of its immunosup-
pressive properties, could induce a state of tolerance to a highly reactive
renal allograft in the rat. Untreated Lewis rats (N = 6), given a major
histocompatibility complex incompatible kidney allograft from Brown-
Norway (BN) rats, rejected the graft within 12 days. Coichicine at the daily
i.p. dose of 40 (N = 6) or 10 (N = 4) jsg/kg promoted long-term survival
of kidney graft (>170 days). Decreasing the dose of coichicine to 4
jxg/kg/day (N = 4) failed to prevent graft rejection that occurred within 10
days. Experiments have also been performed to evaluate the effect of
colchicine (40 ,ttg/kglday) withdrawal at different time intervals from
transplantation (12, 6, 1 months or 15 days) on allograft survival. Graft
survival after coichicine discontinuation is as follows:
Time post-Tx
Graft surviva
days
1
MST
12 months >80, >80, >80, >80, >80, >80 >80
6 months >80, >80, >80, >80 >80
1 month >80, >80, >80, >80 >80
l5days 6,7,7,8 7
Animals with prolonged graft survival had a normal renal function (serum
creatinine 30 days after coichicine withdrawal: 0.80—0.98 mgldl). In vitro
mixed lymphocyte culture experiments using lymphocytes from the same
rats showed a significant reduction of the proliferative response when
challenged with BN lymphocytes (relative response: 20%, 25%, and 18%
vs. 100% in non-transplanted control rats). The present data could be
taken as evidence that colchicine induces a state of unresponsiveness to
kidney graft and may have possible implications for clinical transplanta-
tion.
Kidney transplant in patients with ADPKD: Epidemiological data,
surgical pretranspiant corrections, and transplant outcome. A single
center experience. M. Salvador, E. Bertoni, L. Comparini, S. Bandini, A.
Rosat4 and P. Tosi, Department of Nephrology, Careggi Hospital, Florence,
Italy. We reviewed the charts of 164 patients on the waiting list in our
transplant center over the last two years. Thirty-one patients were affected
by ADPKD, 133 by other nephropathies (ON), and 36 were transplanted
in the 2 years which were considered. The prevalence on the waiting list of
the ADPKD patients was 18.9%. The mean age of the patients at
presentation for the waiting list was 53.12 5.4 years for ADPKD patients
versus 43.29 11.23 years for patients with ON. ADPKD patients did
receive a mean of 0.9 blood units compared to 1.96 for patients with ON.
Mean daily urine output was about 700 dl in the case of ADPKD patients
versus 350 dl in patients affected by ON. Mean blood Hb was 10.25 g/dl for
ADPKD patients versus 9.05 g/dl for patients with ON. Pretransplant
nephrectomy was performed in 11 patients with ADPKD. In 5 patients
autologous blood previously collected was utilized in order to avoid
sensitization and infections. On the whole, 8 patients with ADPKD and 28
patients with ON have been transplanted. One year actuarial graft survival
in ADPKD patients was 100% versus 86% graft survival rate for patients
affected by ON. Major clinical problems in the post-transplant period in
the case of ADPKD patients have been eiythrocytosis and higher CsA
blood levels, mainly in patients affected by cystic liver disease. Prevalence
of ADPKD in patients on the waiting list is higher with respect to the
prevalence of ADPKD patients with ESRD. ADPKD patients have a
higher mean age (P  0.01), higher blood Hb, and higher urine output.
These facts reflect better clinical conditions. The main surgical correction
for ADPKD patients is nephrectomy, which should be performed by
autohemotransfusions in order to avoid sensitization. A good graft
outcome is higher for patients with ADPKD (P  0.01).
Assessment of coronary risk in asymptomatic elderly candidates for
renal transplantation (RT) with dipyridamole Tc-MIBI spect (DMS) and
coronary angiography (CA): Results and critical evaluation. G. Squicci-
marro, G.P. Segoloni, M Baccega, A. De Berardinis, and A. Vercellone,
Divisions of Nephrology, Cardiology, and Nuclear Medicine, S. Giovanni
Hospital, Turin, Italy. Asymptomatic coronary artery disease (CAD) is one
of the most important risk factors in RT either for early or long-term
mortality (50% of cardiovascular early exits for recipients more than 55
years old, in our experience). Since 1992 we routinely perform DMS (cost:
$440) as a preoperative screening of asymptomatic non-diabetic patients
55 years old, and CA (cost: $880) for DMS+ patients only. Eighty-two
patients were studied: mean age 60 32 years (range 55—69, median
59.4), mean duration of RDT 66.1 61 months (range 4—260, median
45.5). In 64/82 cases DMS did not show myocardial ischemia, and 10/64
patients have been transplanted, with no cardiac mortality in the follow-
up. In 18/82 patients (22%) DMS showed myocardial perfusion defects;
12/18 underwent CA up to now: one had a normal finding, 4 showed
"subcritical" CAD (2 transplanted, 2 still on the waiting list), 7/12 showed
critical (70%) CAD (2 excluded from the waiting list by the cardiologist
for trivasal disease, 5 accepted by the cardiologist but excluded by the
transplantation team). We believe that this two-step screening may be
useful in ruling out among asymptomatic patients those (22% of elderly
patients) with CAD consistent with a higher risk of cardiac complications
in the post-transplant period. Once the coronaric damage is assessed,
however, it seems suitable to accept CAD critical patients on the waiting
list (and in some instances also subcritical) taking into account not only
the cardiologist's advice, but also a comprehensive clinical evaluation by
the transplantation team. Further investigations are needed to decide if
the acceptance of patients with subcritical lesions is suitable in terms of
cost/benefit balance.
Renal transplantation in microscopic polyarteritis with persistent
anti-myeloperoxidase antibodies. G.M. Frascà, L.C. Borgnino, L. Neri, M
Martello, E. Sestigiani, and V Bonomini, Institute of Nephrology, University
of Bologna, Bologna, Italy. Microscopic polyarteritis (MPA) is frequently
associated with necrotizing crescentic GN which may progress towards
ESRD, requiring renal replacement treatment with dialysis or transplan-
tation. In most cases anti-neutrophil cytoplasmic autoantibodies specific
for myeloperoxidase (MPO-ANCA) can be detected. Their possible
persistence in the circulation for a long time raises the problems of the
safety of renal transplantation, the possibly increased risk of recurrence,
and the most appropriate immunosuppressive regimen. This study reports
on 3 patients (1 M, 2 F; age 18—43 years) on regular dialysis for crescentic
GN associated with MPA and a persistently high titer of MPO-ANCA
without any clinical manifestations of vasculitis. They underwent renal
transplantation from a cadaver donor 6—63 months after the onset of the
disease. The immunosuppressive protocol included: (a) methyipred-
nisolone (initial dosage: 15 mg/kg/day, tapered to 0.5 mg/kg/day after 4
weeks, and to 0.3 after 8); (b) cyclosporine (initial dosage: 7 mg/kg/day);
(c) azathioprine (initial dosage: 2 mg/kg/day). Graft function recovered in
all patients immediately after surgery, and the MPO-ANCA titer progres-
sively decreased. One patient underwent transplantectomy for surgical
complications 3 months later, while the serum creatinine was 2.1 mg%; the
remainders have a well-functioning graft after 21 and 38 months, respec-
tively, there is no clinical sign of disease recurrence, and MPO-ANCA
titer is within the normal range. We conclude that MPA patients can
undergo renal transplantation even if ANCA persists at a high titer in the
circulation. In this case, immunosuppressive therapy with steroids, cyclo-
sporine and azathioprine seems an appropriate treatment protocol.
14.0 14.2 14.4 14.6 14.8
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Is a specific peritoneal equilibration test (PET) needed for tidal
peritoneal dialysis (TPD) prescription? A. Edefonti, M Picca, G. Con-
salvo, L. Ghio, M. Giani, B. Damiani, A. Dal Col, and R. Galato,
Department of Pediatrics II, University of Milan and Division of Nephrology,
Niguarda Hospital, Milan, Italy. The prediction of suitability of patients for
TPD treatment based on the PET is hypothetically susceptible to errors,
due to the difference between the long equilibration times of the PET and
the short dwell times currently used during TPD, as well as to the different
way equilibration between dialysate and plasma is achieved during TPD
compared to other PD modalities. The relationship between PET-derived
solute clearances and measured solute clearances should therefore be
reassessed for TPD. Eleven patients (mean age 12.4 3.3 years, mean
body weight 34.2 15 kg) underwent both a standardized TPD run (initial
fill volume 40 mllkg, tidal volume 50%, dwell time 10 minutes, treatment
time 8 hours) and PET was performed. DIP ratios for creatinine and urea
were calculated at the 5th and 7th TPD exchanges (approximating the
equilibration time of the TPD run) at the time points of the PET and on
the total TPD dialysate volume.
PET
120 5th TPD 7th TPD Total
minutes exchange exchange TPD
DIP creatinine 0.65 0.17 0.28 0.14 0.27 0.13 0.27 0.10
,'
0
= 0.87 *r = 0.96 °r = 0.98
P < 0.005 P < 0.0001 P < 0.0001
D/P urea 0.80 0.11 0.42 0.15 0.42 0.15 0.40 0.12
____________
*
= 0.63 *r = 0.95 °r = 0.98
P < 0.05 P < 0.0001 P < 0.0001
Correlation coefficients between 15, 30 and 60 minute PET-derived DIP
ratios and total TPD dialysate-derived DIP ratios were poor. In conclu-
sion, it is possible to predict TPD solute clearances, and consequently the
suitability of patients for TPD, based on the DiP ratios for creatinine and
urea at the 7th TPD exchange of a standardized TPD run. This index could
represent a new test for TPD prescription, more reliable than the standard
PET and easier to perform than the direct measurements on the total TPD
dialysate volume.
The antiphospholipid antibodies (APA) in SLE: Symptomatic therapy
or war to the knife? S. Ferrero, C. Canavese, M. Dogliani, A. Thea, P.
Stratta, and A. Vercellone, Department of Nephrology, University of Turin,
Turin, Italy. The therapeutic choice in SLE with APA is not defined: it is
uncertain if it is enough to employ symptomatic therapies (antiaggregant
or anticoagulant) to prevent thrombotic complications or if it is mandatory
to use an immunosuppressant in order to delete these antibodies in the
hypothesis that APA plays a pathogenetic role. In 34 cases of SLE with
APA in the last 10 years, APA were only transiently positive in 16 patients
(group A), while persistent in 18 (group B). The most striking clinical and
biochemical differences between the two groups were the higher frequency
of lupus-like syndrome (5.5% vs. 50%), thrombocytopenia (22% vs. 82%),
microangiopathic hemolytic anemia (0% vs. 25%) and association of high
titer ELISA detectable APA to functional LLAC demonstration (25% vs.
69%) in group B. Only in this group was thrombosis recurrent, despite
prolonged immunosuppressive treatment, antiaggregant therapy, and low
dosage anticoagulant schedules. We conclude that APA seems to belong
to two different subsets: "rouge" APA are hard to be deleted. Before a
clear pathogenetic role is demonstrated, an aggressive immunosuppressive
therapy does not seem to be justified.
High dosage oral calcitriol (C) and zero calcium solutions in CAPD
patients. R. Scanziani, B. Dozio, F. Malberti, B. Corradi, E. Imbasciati, and
M Sudan, Renal Units, Desio and Lodi, Italy. Oral intermittent C is
effective in severe hyperparathyroidism (HPTH) of some CAPD patients
refractory to continuous administration, but its use is limited because of
the occurrence of hypercalcemia. For this reason, in 9 patients with severe
HPTH we induced a negative peritoneal balance of calcium (—417 48
mg124 hr) by using zero Ca bags, in order to treat the patients with high
dose oral C (4 sg X 3/week) and non-aluminum phosphate binders (CaAc
1.2 0.8 and MgCO 1.9 1.6 g of Ca and Mg elements). After the
occurrence of hypercalcemia C was reduced or suspended in 2 patients
after 2 or 3 months. The lowest values of PTH were achieved after 15 days
in 7/9 patients, when C was in the therapeutic range in all the patients and
hypercalcemia (PCa> 11.7 mg/dl) was found in 39% of weekly controls.
The decrease in PTH at the end of the study (vs. baseline) was >50% in
2/9 and >20% in 3/9; 4/9 patients were sent to parathyroidectomy for
refractory HPTH (the decrease of PTH was <20% vs. baseline). Shown in
the table are the serum levels of ionized Ca, P, PTI-I and C during the
study and the doses of C administered.
Baseline 15 days 30 days End
Ca mg/dl 5.20 0.2 5.24 0.24 5.40 0.24 5.42 0.21
P mg/dl 6.32 0.6 5.33 1.Oa 4.70 1.3 5.55 0.8
PTHpg/ml 617 382±299" 413313" 496±356
Cpg/ml 10.2 5.9 34.5 160 = 30 19"
C weekly dose 1.8 1.4 9.7 2.9" 8.4 3.8' 5.6 4.2c
ap < 0.05. bp < 0.01. "P < 0.001 vs. baseline.
Conclusions: (1) Peritoneal Ca loss using zero Ca bags does not determine
hypocalcemia and allows the long-term use of large doses of C; (2) the
lowest PTH is observed within 15 days; (3) high dose oral C associated
with zero Ca solutions can effectively suppress PTH secretion in some
CAPD patients, considered refractory with oral continuous treatment.
Pregnancy after kidney transplantation. P. Stratta, on behalf of the
Kidney and Pregnancy Group of the Italian Nephrology Society. Pregnancy
after kidney transplantation has been successful in more than 1,500
women all over the world. Favorable results have been reported in 60 to
92% of pregnancies, depending on the exclusion of abortions and early
complications before the third month. The Kidney and Pregnancy Group
of the Italian Nephrology Society studied pregnancy and kidney outcomes
in 45 patients with 51 pregnancies (one twin birth). The therapy at the
beginning of pregnancy was: steroids (STER) + azathioprine (AZA) (N =
23), STER + cyclosporin A (CsA) (N = 19), STER + AZA + CsA (N
8), AZA + CsA (N = 1); during pregnancy therapy was increased in 4
patients (4 STER), reduced in 3 patients (2 STER + 1 AZA), and stopped
in 2 patients (AZA). We observed 34 regular births, 17 premature births
(33%), and Cesarean sections in 76% of patients. All newborns were alive
at birth; the weight averaged 2.5 0.56 kg. There were 3 perinatal deaths
at 6, 7, 27 days after delivery, respectively). We observed: 2 malformations
(interventricular communication, bowel athresy), and 2 perinatal compli-
cations (3.8%). Blood creatinine and proteinuria changed respectively
from 1.12 0.30 mgldl and 40 72 mg124 hr before pregnancy to 1.22
0.6 and 155 89 one month after delivery, to 1.4 1.4 and 654 2290
(2 patients 1 g/24 hr) 12 months after delivery. Maternal complications
were: 1 interstitial acute rejection (1.9%) at 1 month after delivery, 3
preeclamptic episodes (5.8%), 4 urinary tract infections (7.9%), and 1
colestatic jaundice. Blood pressure remained unvaried before and after
pregnancy (in 3 patients only was a hypotensive therapy added). Our
experience confirms good results obtained in pregnancy after kidney
transplantation; careful choice of patients is needed, according to Davi-
son's criteria. Maternal and fetal risks could be reduced by careful
interdisciplinary check-up.
Effects of nitrendipine (NT) on urinary enzyme and protein excretion
after non-ionic radiocontrast (RC) administration. M Carraro, W. Man-
cmi, M. Artero, F. Stacul, M Grotto, and L. Faccini, Institutes of Patologia
Medica and Radiologia, University of Trieste, Trieste, Italy. The effects of
single doses of a calcium antagonist on urinary enzyme and microprotein
excretion after non-ionic RC administration were studied in a controlled,
randomized, double blind protocol consisting of 121 patients (mean age
65.3 9.3 years; 62% male) with normal renal function who were to
undergo digital subtraction angiography (DSA). The.patients were treated
with placebo or NT 10 mg or 20 mg p.o. 1 hour before DSA. Blood and
urine samples were collected 1 hour before and after and 24 hours after
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DSA. Study variables included: contrast volume, serum creatinine, Na, K,
and osmolality; urinary creatinine, osmolality, albumin, alanylaminopep-
tidase (AAP), N-acetyl-/3-glucosaminidase (NAG), and n-1-microglobulin
(a1m). AAP, NAG, and a1m increased following RC administration, all
except AAP returning to baseline after 24 hours. Pretreatment with NT
had no protective effect on enzyme excretion, although AAP levels were
lowered in general with the 20 mg dose. The incidence of acute renal
failure 24 hours after DSA was equal in the three groups. This study
indicates that a single low or normal dose of NT p.o. is not an effective
prophylaxis before RC administration, perhaps due to hepatic first-pass
kinetics.
Intraindividual variability of cyclosporine blood trough levels on pa-
tients' immunosuppression. A. E114 P. Palazzi, F. Nicosia, S. Zafiropulu,
and F. Quarto di Palo, Clinica Medica 1, Transplant Unit, Università di
Milano, Milano, Italy. In this study we evaluated the practical importance
of CSA trough blood levels intraindividual variability in a group of 100
non-immunized cadaver renal transplants. During a five year period we
calculated in each patient blood mean CsA level and its variation
coefficient (CVC). The mean intraindividual variability of CsA blood
levels was 25.3% (mm 5, max 71%, the median 27.7%). Patients were
divided into two groups: Group A with a CVC < 28%, group B with a
CVC > 28%, and they were compared for graft function and survival.
Patients of group A showed a great stability in renal function and in the 5
year observation period only 10.5% of the kidneys were lost for rejection.
In patients of Group B plasma creatinine levels increased in time from 122
3.8 to 179 11.5 zmIliter at the 5th year (P < 0.001). Creatinine
clearance decreased (P < 0.05) and a greater number of graft losses(31.9%) was also observed. After the 1st year of observation the survival
curves and the data of the two groups were statistically different. In
conclusion, an elevated intraindividual variability of CsA trough blood
levels is associated with an increased risk of renal function deterioration
and graft loss.
Short-term immunosuppression with CTLA4Ig, a soluble form of the T
cell activation molecule CD28: Prolonged renal allograft survival in rats.
G. Remuzzi, 0. Imberti, M. Bontempelli, and N Perico, Mario Negri Institute
and Ospedali Riuniti, Bergamo, Italy. Allograft rejection is a process that
depends on T cell receptor-ligand interaction and costimulatory signals
generated when accessory molecules bind to their ligands, such as CD28 to
the B7 molecule. We investigated the possibility that B7 blockade in vivo
by the soluble CD28 receptor homolog CTLA4Ig modulates the rejection
process in a rat model of kidney allograft. Lewis rats orthotopically
transplanted with MHC incompatible kidney from Brown-Norway (BN)
rats were given an i.p. injection of CTLA4Ig (0.2 or 0.5 mg/day) or a
non-specific immunoglobulin (Ig 0.5 mg/day) for 7 days, starting the day of
transplant. Graft survival is as follows:
Graft survival
days Median
CTLA4Ig 0.2 mg/day 36, 40, 43, 45, 47, 50 44
CTLA4Ig 0.5 mg/day 40, 48, 50, 55, 60 50
Ig 0.5 mg/day 8, 8, 9, 10, 10 9
In all CTLA4Ig-treated rats renal grafts were well functioning 30 days
after transplantation as documented by serum creatinine concentrations,
comparable to age- and sex-matched control rats (0.65 0.08 mg/dl). At
this time in vitro mixed lymphocyte culture experiments showed a signif-
icant reduction of proliferation of peripheral blood lymphocytes from
CTLA4Ig-treated rats when challenged with BN, but not third party
Wistar Furth lymphocytes. These findings indicate that: (1) the interaction
between CD28 and B7 is an essential costimulatory signal in the process of
allograft rejection; (2) a short-course of CTLA4Ig prolonged renal
allograft survival in the rat.
Immunohistochemical distribution of adhesion molecules on biopsies
of well-functioning renal transplantS. L. Murer, G. Basso, G. Montini, R.
Dall'Amico, B. Andreetta, A. Scarpa, E. CurrO-Dossi, and G. Zacchello,
Department of Pediatrics, University of Padova, Padova, Italy. Adhesion
molecules regulate cell-cell and cell-matrix interaction during the immune
response to alloantigens. Up-regulation of ICAM-1 and HLA-DR on
renal tubular cells has been observed during renal allograft rejection, and
endothelin (ET) has been proposed as a proinflammatory agent during
cell-mediated events that include macrophage infiltrate. We have studied
the immunohistochemical distribution of HLA-DR, ICAM-1, VCAM-1,
of leukocyte ligands LFA-1 and VLA-4, and of ET on 18 graft biopsies
obtained from well-functioning renal transplants (serum creatinine x 75.1
jsmol/liter). Interstitial infiltrate was also evaluated. As controls, normal
renal tissues obtained from 4 nephrectomies, were analyzed for renal
carcinoma. In the controls, there was no evidence of inflammation; the
tubules were HLA-DR and adhesion molecule negative, and ICAM-1 and
VCAM-1 were expressed only by glomerular and interstitial capillaries
and by Bowman's epithelial cells, respectively. ET staining was absent or
weak only on vascular endothelium. Inflammatory infiltrate was observed
in 12/18 renal graft biopsies (4 severe, 3 moderate, 5 weak); in all of the
biopsies, 90% of infiltranting cells were LFA-1 positive and a severe
positivity (+cells > 50/area) was present in 9/18 cases. In 3/18 biopsies a
severe VLA-4 positivity was also revealed. Tubular cells expressed
HLA-DR in 17/18 cases, ICAM-1 and VCAM-1 in 16/18 and a severe
positivity (+ tub.sec. > 3/area) was detected in 7/18, 4/18 and 3/18
biopsies, respectively). ET was expressed by infiltranting cells in 8/18 and
by tubules in 4/18 cases. A statistically significant correlation was present
between the expression of HLA-DR and of the integrins by tubular cells,
and the degree of inflammation and LFA-1, VLA-4 and ET positivity of
infiltranting leukocytes. These preliminary results underline the central
role of the tubular epithelial cell as both a target and an accessory cell of
the allograft immune response. In 20% of our biopsies obtained from
renal transplants with no clinical evidence of rejection, a severe infiltrate
was observed in the presence of up-regulation of HLA-DR and of
adhesion molecules on tubules. The influence of ET on cell-cell interac-
tions during immune response needs further investigation.
Expression of l3 and 133 integrins and ICAM-1 and VCAM-1 counter-
receptors in crescentic glomerulonephritis (CGN).A. Baraldi, L. Furci, G.
Zambnmo, D. Ottani, M. Ballestri, S. Pen-one, A. Di Felice, and E.
Lusvarghi, Department of Nephrology and Dermatology, University of Mod-
ena, Modena, Italy. In CGN, cytokines produced by resident and infiltrat-
ing cells have been reported to increase extracellular matrix (EM)
deposition and to modulate the expression of EM receptors. In the present
study, the expression of j31(a1-a6) and a133 integrin receptors and
ICAM-1 and VCAM-1 counter-receptors (CR) was evaluated on renal
biopsies of 5 patients affected by CGN using an immunohistochemical
technique. Indirect immunofluorescence showed C3 and IgG immune
deposits (ID) in 2 cases, while no ID were found in the 3 patients with
anti-cytoplasmic antibodies. The expression and distribution pattern of
integrins, ICAM-1 and VCAM-1 were similar in both types of CGN. On
collapsed flocculi, the expression of a1, a2, a3, a5, a6, a subunits and
ICAM-1 was regularly very low. On each cell of recently developed
crescents, a3, a, ICAM-1 and VCAM-1 were strongly expressed, while a4
and a5 stained clusters of infiltrating leukocytes. Only trace amounts of all
the adhesion molecules examined were detected in fibrous crescents. In
the periglomerular areas presenting a heavy infiltrate, ICAM-1 was
detected on the brush border of 40—80% of tubuli, and a basolateral
expression of a2, a3, a5, a,, subunits and VCAM-1 was found on 70—100%
of the tubuli. The expression of different adhesion molecules on cellular
crescents and the marked up-regulation of the same molecules on tubuli
may be due to the increased production of cytokines, in particular TGF-13,
in this highly aggressive GN.
New markers in the evaluation of persistent hyperparathyroidism after
kidney transplantation. F. Vaccaro, A. Pagano, MC. Gioviale, S. Cavera,
F.P. Picone, and M Romano, Chair of Surgical Pathology "R", Department
of Hemodialysis, Nephrology and Organ Transplantation, University of
Palermo, Palermo, Italy. Although kidney transplantation removes the
metabolic stimuli leading to secondary hyperparathyroidism (HPT), the
excessive excretion of parathyroid hormone (PTH) may persist or return
after the transplant. Several authors report cases of latent HPT in kidney
transplant patients with normal calceniia, which in time may lead to loss of
bone mass. At the present time, the most widespread biochemical markers
of bone reabsorption are urinary pyridinoline (Pyd) and deoxypyridinoline(Dpd). The aim of our study was to evaluate the bone turnover of kidney
transplanted patients with normal calcemia and iPTH levels at the upper
normal limits. We determined the urinary concentration of the collagen
cross links (Pyd and Dpd) (Elisa, Metra Biosystems, USA) in 20 patients
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who had successfully undergone kidney transplants (13 men and 7 women,
mean age 43.7 8.2 years, mean transplant age 30.4 12.1 months,
creatinemia 168.8 13.3 nmol/liter). We also determined serum param-
eters such as calcemia, phosphoremia, alkaline phosphatase (ALP), iPTH,
bone osteocalcin (BGP), and urinary levels of calcium and phosphorous.
All the patients in the group had suspended any drug treatment which
might interfere with bone metabolism at least 1 month previously. The
table shows the date obtained, with high levels of urinary cross links
compared to normal calcemia, phosphoremia and BGP levels, which
might suggest a linear correlation with the high levels of iPTH (r = 0.37;
P < 0.05).
Ca = 2.71 1.1 nmol/liter
P = 1.01 0.6 nmol/liter
iPTH = 75.8 6.2 pg/mI
ALP = 190 36.7 U/liter
BGP = 25.2 6.1 ngJml
C5.,rina,y = 307.4 64.3 mg/24 hr
urina,y = 1090.1 85.4 mg/24 hr
Pydurinary = 97.5 10.3 nM/mM Cr
DYdurinary = 97.5 10.3 nM/mM Cr
Pyd/Dpd = 3.6 0.8
In conclusion, our data indicate that urinary evaluation of cross links
might reveal any increase in bone reabsorption due to persistent HPT,
even when other more common markers prove to be within normal limits.
Local transcription of complement C3 in human renal allograft rejec-
tion.A. Pani, PA. Andrews, W. Zhou, A. Altieri, and S.H. Sacks, Divisione
di Nefrologia, Ospedale S. Michele, Cagliari, Italy, and Department of
Nephrology, UMDSs of Guy's and St. Thomas' Hospital, Guy's Campus,
London, England, United Kingdom. Normal renal tissue is able to synthe-
size several complement components, including C3 and C4. The patho-
genic role of complement has been well characterized in hyperacute
(antibody-mediated) rejection, but little is known about the role of
complement in acute cellular rejection. We therefore investigated the role
of intrinsic renal production of C3 in acute renal allograft rejection, and
whether local C3 production is correlated with histological and clinical
outcomes. Thirty biopsies of renal transplant cortex were compared to
cortical tissue from 7 normal kidneys. Cortex was processed immediately,
and all biopsies were performed for standard clinical indications. Total
RNA was extracted using a microadaptation of single step phenol-
chloroform technique, and first strand eDNA synthesis performed from
mRNA using oligo(dt) 12—18. C3 eDNA fragments were then co-amplified
in the same tube in the presence of [32p] dCTP and PCR primers specific
for a control (housekeeping) gene, glucose-phosphate-isomerase (UPI).
Results were expressed as the ratio of the intensity of the C3 product to
that of the GPI band on autoradiography. The presence of mRNA
transcript for C3 was confirmed in all normal tissue and transplant
biopsies. Overall, 24/30 transplant biopsies exhibited a higher C3 expres-
sion than the maximum control tissue (mean 0.40 0.10 SEM biopsies vs.
0.038 0.009 controls, P < 0.005). In those patients with clinical and
histological evidence of pure cellular rejection, however, 13/14 biopsies
had an increased C3 expression (mean 0.51 0.085, P < 0.005). In
contrast, 4/5 biopsies showing pure cyclosporine toxicity had normal C3
expression. There was a significant correlation between C3 mRNA
expression and the amount of C3 deposited in the tubular basement
membrane (r = 0.43, P < 0.005). In contrast, there was no correlation
between C3 expression and mononuclear cell infiltration. We concluded
that local renal C3 synthesis is increased in acute allograft rejection but is
poorly correlated with cellular infiltration. Local C3 synthesis may play a
role in acute rejection and should be explored further.
Peritoneal dialysis prescription: The "clearance peak" model. G. Vi,a,
G. Amici, G. Da Rin, A. da Porto, and C. Bocci, Nephrology Division and
Laboratory, Treviso Hospital, Treviso, Italy. Peritoneal dialysis prescription
involves setting up a personalized dialysis schedule aimed at obtaining
satisfactory clearance and ultrafiltration rates while respecting the pa-
tient's lifestyle as far as possible. By calculating the creatinine clearance
(Ccr) from 2 exchanges with dwell times (DT) of 4 and 8 hours,
respectively (2 liters, 2.27%) in 21 uremic patients (age 62.7 10.5 years,
on CAPD for 23 18 months), curves (y = ah2 + bh + c) were plotted
with 3 points (0, 4, 8 hr) for Cr (y) and volume (Vol, y) as a function of
the DT (h). The DT corresponding to the Ce,. peak (CIPeak-t, range: 4 hr
35 mm—il hr 10 mm) was calculated for each subject with the 1st
derivative (h =
—b/2a) of the function. On the basis of the Cr that can be
obtained with the 3 most common DT (4, 6, 8 hr), we divided the patients
into 3 categories (CI peak-t < 5 hr: "fast"; 5—7 hr: "normal"; >7 hr:
"slow") for the best C. correspondence of the 4, 6 or 8 hour exchanges,
respectively. Also, the Cr (y) and Vol (y) 8 hr/4 hr ratios were related to
CI Peak-t (h) (y = ah2 + bh + c, r2 = 0.983 and 0.781, P < 0.001).
Fast
(N=1)
Normal
(N=11)
Slow
(N=9)
ClPeak-t (h) <5 5 to 7 >7
Criterion (Car) 4 hr> 6 hr
>8hr
4 hr < 6 hr
>8hr
4 hr < 6 hr
<8hr
Ccr 8 hr/4 hr <0.68 0.68—1.19 >1.19
Vol 8 hr/4 hr <0.60 0.60—0.94 >0.94
1st choice APD CAPD (6 hr X 4) CAPD (6 hr
x 4)
2nd choice DAPD (4 hr x 4) DAPD (4 hr X 4) CAPD (8 hr
x
a (6 hr X 4): ¾ bags—1.36% for normal, ¼—1.36% for slowb (8 hr X 3): bag volume from +25% (CIPeak-t = 7 hr) to +10% (9
hr)
The "CIPeak" model identifies the most advantageous DT for each
patient by using the C. values of two 2.27% exchanges of 4 and 8 hours,
respectively. Functional classification into 3 categories may give a rational
orientation to dialysis prescription.
Can asymptomatic women carriers of the Alport syndrome gene be
accepted as living kidney donors? A. Pietrucc4 M. Meroni, S. Carozzi, S.
Tazzari, L. Tom Tarelli, F. Giordano, A. Renieri, M. De Marchi, U Valente,
and A. Sessa, Units of Nefrologia e Dialisi, Savona e Vimercate; Anatomia
Umana Normale, Milano; Anatomia Patologica, Vimercate; Genetica Med-
ica, Siena; Chirurgia Trapianti, Genova, Italy. Female carriers of the Alport
syndrome (AS) gene should avoid living kidney donation even though
oligosymptomatic, because of the risk of progression of the glomerular
lesions in the remnant nephrons; for the same reason, the survival of the
grafted kidney may be limited. We observed two transplanted brothers
affected with AS, receiving the kidneys from the father (Tpl) and the
mother (Tp2), respectively. Molecular analysis showed linkage with
COL4A5 gene on the X chromosome, but so far direct search did not
succeed in revealing the gene defect on the examined exons. Two years
after transplantation, Tpl was well-functioning; Tp2 had a mild deterio-
ration in GFR for a recent episode of rejection and a subsequent CMV
infection. The mother presented microscopic hematuria and normal GFR.
A graft biopsy was performed in Tp2 because of persistent microscopic
hematuria and glomerular proteinuria: LM showed non-specific glomer-
ular alterations, tubulointerstitial infiltrates and segmental arteriolar
thickening. IF was negative, and EM showed an appearance of the
glomerular basement membrane consistent with AS. Renal transplanta-
tion in AS raises some questions: (1) the low prevalence of anti-GBM
nephritis does not contraindicate transplantation in AS and also from a
living healthy father; (2) the living donation is not advisable in females
with relevant lesions of the GBM, proteinuria, deafness and/or typical
ocular abnormalities; (3) female carriers of the AS with isolated micro-
scopic hematuria may be evaluated as living kidney donors, as long as a
long-term follow-up will not provide evidence for an increased risk of
progression to ESRD in the remaining kidney.
